Cargando…

Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells

Glycosaminoglycans (GAGs) and proteoglycans (PGs) are major components of the glycocalyx. The secreted GAG and CD44 ligand hyaluronic acid (HA), and the cell surface PG syndecan-1 (Sdc-1) modulate the expression and activity of cytokines, chemokines, growth factors, and adhesion molecules, acting as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valla, Sofía, Hassan, Nourhan, Vitale, Daiana Luján, Madanes, Daniela, Spinelli, Fiorella Mercedes, Teixeira, Felipe C. O. B., Greve, Burkhard, Espinoza-Sánchez, Nancy Adriana, Cristina, Carolina, Alaniz, Laura, Götte, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198019/ https://www.ncbi.nlm.nih.gov/pubmed/34070901 http://dx.doi.org/10.3390/ijms22115874

Ejemplares similares

The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis
por: Hillemeyer, Lara, et al.
Publicado: (2022)

The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor
por: Hassan, Nourhan, et al.
Publicado: (2023)

Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes
por: Nassar, Eyyad, et al.
Publicado: (2021)

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
por: Hilgers, Katharina, et al.
Publicado: (2022)

Hyaluronan Metabolism is Associated with DNA Repair Genes in Breast and Colorectal Cancer. Screening of Potential Progression Markers Using qPCR
por: Sevic, Ina, et al.
Publicado: (2020)

The immunological effect of hyaluronan in tumor angiogenesis
por: Spinelli, Fiorella M, et al.
Publicado: (2015)

Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells
por: Katakam, Sampath Kumar, et al.
Publicado: (2020)

Targeting the Tumor Extracellular Matrix by the Natural Molecule 4-Methylumbelliferone: A Complementary and Alternative Cancer Therapeutic Strategy
por: Vitale, Daiana L., et al.
Publicado: (2021)

Syndecan-1 as a Regulator of Chemokine Function
por: Götte, Martin, et al.
Publicado: (2003)

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2017)

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
por: Ibrahim, Sherif A., et al.
Publicado: (2013)

Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells
por: Vitale, Daiana L., et al.
Publicado: (2021)

Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer
por: Onyeisi, Jessica Oyie Sousa, et al.
Publicado: (2021)

Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expression
por: Vitale, Daiana L., et al.
Publicado: (2018)

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
por: Robinson, Brian D., et al.
Publicado: (2019)

Syndecan-1 expression has prognostic significance in head and neck carcinoma
por: Anttonen, A, et al.
Publicado: (1999)

Role of syndecan-1 in the interaction between dendritic cells and T cells
por: Kouwenberg, M., et al.
Publicado: (2020)

Physiological and anatomical aspects of the reproduction of mice with reduced Syndecan-1 expression
por: Gougoula, Christina, et al.
Publicado: (2019)

High molecular weight sodium hyaluronate improves survival of syndecan-1-deficient septic mice by inhibiting neutrophil migration
por: Baljinnyam, Tuvshintugs, et al.
Publicado: (2021)

Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
por: Oto, Julia, et al.
Publicado: (2023)

Smoking has disruptive effects on the small bowel luminal microbiome
por: Leite, Gabriela, et al.
Publicado: (2022)

The heparan sulfate proteoglycan Syndecan-1 influences local bone cell communication via the RANKL/OPG axis
por: Timmen, Melanie, et al.
Publicado: (2020)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
por: Hassan, Nourhan, et al.
Publicado: (2020)

Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma
por: Binder Gallimidi, Adi, et al.
Publicado: (2017)

Sexo, amor y violencia : estrategias de transformación /
por: Madanes, Cloé
Publicado: (1993)

Violencia masculina /
por: Madanes, Cloé
Publicado: (1997)

Finding Time: How the COVID-19 Pandemic Revealed Flexibility in Residency Training
por: Madanes, Sharon
Publicado: (2022)

Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth
por: Zamloot, Vic, et al.
Publicado: (2022)

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
por: Götte, Martin, et al.
Publicado: (2007)

Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns
por: Baston-Büst, Dunja M, et al.
Publicado: (2010)

Syndecan-Regulated Receptor Signaling
por: Rapraeger, Alan C.
Publicado: (2000)

Syndecan-3 gets the message
por: Leslie, Mitch
Publicado: (2011)

The Cardiac Syndecan-2 Interactome
por: Mathiesen, Sabrina Bech, et al.
Publicado: (2020)

Syndecan-3 in Inflammation and Angiogenesis
por: Arokiasamy, Samantha, et al.
Publicado: (2020)

Syndecans in Inflammation at a Glance
por: Gopal, Sandeep
Publicado: (2020)

Syndecan-1 in Liver Diseases
por: Regős, Eszter, et al.
Publicado: (2019)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Depletion of Luminal Pyridine Nucleotides in the Endoplasmic Reticulum Activates Autophagy with the Involvement of mTOR Pathway
por: Kapuy, Orsolya, et al.
Publicado: (2013)

Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier
por: Chiang, Huai-Chin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_voplo6ean6dvu7lgihf2bj32m1